A strong marketing application depends on more than the evidence itself. It must also be complete, technically compliant, internally consistent, and organized to support regulatory review. Gaps in regulatory commitments, CMC and manufacturing, datasets, labeling, or submission operations can become significant filing risks when they surface too late.
This eBook explores how to prepare earlier, assess readiness once the development program is mature enough to evaluate, prioritize the gaps that matter most, align with health authorities, and bring scientific, regulatory, and operational workstreams together around one integrated submission plan.
What’s Inside
- When to begin a formal readiness assessment—and why preparation should start much earlier
- How to identify and prioritize gaps across regulatory, CMC, nonclinical, clinical, data, and labeling workstreams
- How to use pre-submission agency meetings to address unresolved filing risks
- How regulatory operations, progressive publishing, and integrated planning can support a more controlled submission build